Putnam Investments’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-521,900
Closed -$17.9M 1608
2014
Q4
$17.9M Sell
521,900
-334,769
-39% -$10.9M 0.04% 359
2014
Q3
$25.6M Sell
856,669
-164
-0% -$3.48K 0.05% 280
2014
Q2
$17.2M Sell
856,833
-329,486
-28% -$7.56M 0.04% 355
2014
Q1
$32.2M Sell
1,186,319
-1,510,442
-56% -$40.1M 0.07% 259
2013
Q4
$55.9M Sell
2,696,761
-176,957
-6% -$3.34M 0.13% 172
2013
Q3
$52.4M Buy
2,873,718
+2,650
+0.1% +$47.9K 0.14% 173
2013
Q2
$47.7M Buy
+2,871,068
New +$45.9M 0.14% 177

Other funds holding AUXL

Putnam Investments's AUXL Position: Q1 2015 in Review

Putnam Investments sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 521,900 shares — an estimated $17.9M sold.

Putnam Investments first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $55.9M in Q4 2013. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Putnam Investments reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Putnam Investments sold 521,900 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $17.9M.
  • Putnam Investments first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Putnam Investments's AUXILIUM PHARAMCEUTICALS INC position peaked at $55.9M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Putnam Investments's 13F filing for Q1 2015, filed 15 May 2015.